499 related articles for article (PubMed ID: 18174268)
1. The cost of renal dialysis in a UK setting--a multicentre study.
Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K
Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
[TBL] [Abstract][Full Text] [Related]
3. Current costs of dialysis modalities: A comprehensive analysis within the United Kingdom.
Roberts G; Holmes J; Williams G; Chess J; Hartfiel N; Charles JM; McLauglin L; Noyes J; Edwards RT
Perit Dial Int; 2022 Nov; 42(6):578-584. PubMed ID: 35068280
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis of dialysis modalities in Italy.
Tediosi F; Bertolini G; Parazzini F; Mecca G; Garattini L
Health Serv Manage Res; 2001 Feb; 14(1):9-17. PubMed ID: 11246787
[TBL] [Abstract][Full Text] [Related]
5. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
7. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
Rodríguez-Carmona A; Perez Fontán M; Bouza P; García Falcón T; Valdés F
Adv Perit Dial; 1996; 12():93-6. PubMed ID: 8865880
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
[TBL] [Abstract][Full Text] [Related]
9. Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements.
Lamas Barreiro JM; Alonso Suárez M; Saavedra Alonso JA; Gándara Martínez A
Nefrologia; 2011; 31(6):656-63. PubMed ID: 22130280
[TBL] [Abstract][Full Text] [Related]
10. [Cost of dialysis in France].
Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
[TBL] [Abstract][Full Text] [Related]
11. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
De Vecchi AF; Dratwa M; Wiedemann ME
Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis.
Agar JW; Knight RJ; Simmonds RE; Boddington JM; Waldron CM; Somerville CA
Nephrology (Carlton); 2005 Dec; 10(6):557-70. PubMed ID: 16354238
[TBL] [Abstract][Full Text] [Related]
13. Health economic evaluations: the special case of end-stage renal disease treatment.
Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
[TBL] [Abstract][Full Text] [Related]
14. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
[TBL] [Abstract][Full Text] [Related]
15. A cost effectiveness analysis of the treatment of end stage renal failure.
Croxson BE; Ashton T
N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness evaluation of the Ministry of Health Malaysia dialysis programme.
Lim TO; Lim YN; Wong HS; Ahmad G; Singam TS; Morad Z; Suleiman AB; Rozina G; Ong LM; Hooi LS; Shaariah W; Tan CC; Loo CS
Med J Malaysia; 1999 Dec; 54(4):442-52. PubMed ID: 11072461
[TBL] [Abstract][Full Text] [Related]
17. The Medicare cost of renal dialysis. Evidence from a statistical cost function.
Dor A; Held PJ; Pauly MV
Med Care; 1992 Oct; 30(10):879-91. PubMed ID: 1405794
[TBL] [Abstract][Full Text] [Related]
18. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
Maxwell JH; Sapolsky HM
Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
[TBL] [Abstract][Full Text] [Related]
19. [Costs of chronic dialysis in a public hospital: myths and realities].
Lamas J; Alonso M; Saavedra J; García-Trío G; Rionda M; Ameijeiras M
Nefrologia; 2001; 21(3):283-94. PubMed ID: 11471309
[TBL] [Abstract][Full Text] [Related]
20. The costs in provision of haemodialysis in a developing country: a multi-centered study.
Ranasinghe P; Perera YS; Makarim MF; Wijesinghe A; Wanigasuriya K
BMC Nephrol; 2011 Sep; 12():42. PubMed ID: 21896190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
